自然杀手细胞模仿低氧反应的纳米药物用于瘤特异性抑制和免疫调节
Jingqiao Wang1, Lingyang Meng1, Fanhu Meng1
1College of Marine Life Science, Ocean University of China, Qingdao, 266003, P. R. China.
Small (Weinheim an der Bergstrasse, Germany)
|September 18, 2025
概括
自然杀手细胞膜纳米粒子将药物输送到瘤中,增强癌细胞的杀死和逆转免疫抑制. 这种NK细胞模仿策略显示出显著的瘤生长抑制和组合治疗的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
- 生物技术是生物技术.
背景情况:
- 自然杀手 (NK) 细胞对于对瘤的天生的免疫力至关重要,但受到瘤微环境的影响.
- 瘤中的缺氧和免疫抑制因素限制了NK细胞的有效性.
- 开发克服这些局限性的策略对于有效的癌症治疗至关重要.
研究的目的:
- 开发NK细胞膜伪装的纳米颗粒 (HSF@NK) 用于铁素和CAIX siRNA的向输送.
- 研究HSF@NK增强瘤特异性细胞毒性和逆转免疫抑制瘤微环境的能力.
- 在临床前瘤模型中评估HSF@NK的治疗疗效.
主要方法:
- 用NK细胞膜 (NKCM) 伪装的低氧反应纳米颗粒的制造.
- 在纳米颗粒中同时传递铁 (Fc) 和碳酸酶IX (CAIX) siRNA.
- 细胞毒性和免疫调节的体外评估.
- 在小鼠模型 (B16F10和4T1) 中瘤生长抑制的体内评估.
- 与抗PD-L1.1.的联合治疗.
主要成果:
- HSF@NK纳米颗粒有效向瘤并逃避免疫清除.
- 缺氧触发了Fc和CAIX siRNA的释放,导致pH值降低和瘤细胞的氧化损伤放大.
- 该治疗诱导了免疫细胞死亡,增强了树突细胞成熟,并促进了M1巨细胞的两极分化.
- 在B16F10模型中观察到显著的瘤生长抑制 (≈85.0%).
- 与抗PD-L1结合,在4T1模型中实现了约92.4%的瘤抑制和长期免疫力.
结论:
- 模仿NK细胞的纳米粒子为固体瘤治疗提供了一种新的策略.
- HSF@NK有效地逆转了免疫抑制瘤微环境,并增强了抗瘤免疫力.
- 这种方法代表了纳米医学在癌症治疗中的有希望的进步.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cells of the Innate Immune Response
8.7K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


